Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kang, Minkyung ^a,b   Ryu, Jihye ^b   Lee, Doohyung ^b   Lee, Mi Sook ^b   Kim, Hye Jin ^b   Nam, Seo Hee ^a   Song, Haeng Eun ^b   Choi, Jungeun ^a   Lee, Gyu Ho ^b   Kim, Tai Young ^b   Lee, Hansoo ^c   Kim, Sang Jick ^d   Ye, Sang Kyu ^a   Kim, Semi ^c   Lee, Jung Weon ^a,b  

^a Seoul National University   (South Korea)

^b Tumor Microenvironment Global Core Research Center   (South Korea)

^c Kangwon National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD151 ANTIGEN; CD63 ANTIGEN; MEMBRANE PROTEIN; TETRASPANIN; TRANSMEMBRANE 4 L6 FAMILY MEMBER 5 PROTEIN; UNCLASSIFIED DRUG; CD151 PROTEIN, HUMAN; CD63 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TM4SF5 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LYSOSOME MEMBRANE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOPRECIPITATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; CARCINOGENESIS; CELL LINE; CELL MOTION; LIVER; LIVER CIRRHOSIS; LIVER TUMOR; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANTIGENS, CD151; ANTIGENS, CD63; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; HEPATOCYTES; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; PHENOTYPE; TETRASPANINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84904488790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102817     Document Type: Article

References (30)

1. Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, Sanchez-Madrid F (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 19: 434-446.
2. Patra SK (2008) Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 1785: 182-206.
3. Detchokul S, Williams ED, Parker MW, Frauman AG (2013) Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol.
4. Sala-Valdes M, Ailane N, Greco C, Rubinstein E, Boucheix C (2012) Targeting tetraspanins in cancer. Expert Opin Ther Targets 16: 985-997.
5. Testa JE, Brooks PC, Lin JM, Quigley JP (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59: 3812-3820. (Pubitemid 29381891)
6. Sincock PM, Mayrhofer G, Ashman LK (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and α5β1 integrin. J Histochem Cytochem 45: 515-525. (Pubitemid 27175796)
7. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, et al. (2007) Deletion of tetraspanin CD151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109: 1524-1532. (Pubitemid 46239585)
8. Yang XH, Flores LM, Li Q, Zhou P, Xu F, et al. (2010) Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res 70: 2256-2263.
9. Pols MS, Klumperman J (2009) Trafficking and function of the tetraspanin CD63. Exp Cell Res 315: 1584-1592.
10. Lekishvili T, Fromm E, Mujoomdar M, Berditchevski F (2008) The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility. J Cell Sci 121: 685-694. (Pubitemid 351524167)
11. Radford KJ, Thorne RF, Hersey P (1997) Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158: 3353-3358. (Pubitemid 127484053)
12. Wright MD, Ni J, Rudy GB (2000) The L6 membrane proteins-a new four-transmembrane superfamily. Protein Sci 9: 1594-1600. (Pubitemid 30659198)
13. Lee SA, Park KH, Lee JW (2011) Modulation of signaling between TM4SF5 and integrins in tumor microenvironment. Front Biosci 16: 1752-1758.
14. Kang M, Choi S, Jeong SJ, Lee SA, Kwak TK, et al. (2012) Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition. Biochem J 443: 691-700.
15. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, et al. (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126: 1005-1014. (Pubitemid 38451172)
16. Severi T, van Malenstein H, Verslype C, van Pelt JF (2010) Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin 31: 1409-1420.
17. Jung O, Choi S, Jang SB, Lee SA, Lim ST, et al. (2012) Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells. J Cell Sci 125: 5960-5973.
18. Jung O, Choi YJ, Kwak TK, Kang M, Lee MS, et al. (2013) The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation. Biochim Biophys Acta 1833: 629-642.
19. Lee SA, Lee SY, Cho IH, Oh MA, Kang ES, et al. (2008) Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest 118: 1354-1366. (Pubitemid 351500429)
20. Kim H-P, Kim T-Y, Lee M-S, Jong H-S, Kim T-Y, et al. (2005) TGF-[beta]1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27Kip1 CDK inhibitor in hepatoma cells replated on fibronectin. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1743: 151-161. (Pubitemid 40380615)
21. Kim SM, KS, Min HJ, Song JM, Lee JW, Kim HJ (2012) A novel TM4SF5 specific monoclonal antibody and use thereof. Korean Patent 10-2012-0085436 and 10-2012-0085437.
22. Lee SA, Kim TY, Kwak TK, Kim H, Kim S, et al. (2010) Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis. J Cell Biochem 111: 59-66.
23. Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, et al. (2009) Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology 50: 1524-1536.
24. Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM, et al. (2006) Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem 281: 24279-24292.
25. Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6: 801-811.
26. Lee SY, Kim YT, Lee MS, Kim YB, Chung E, et al. (2006) Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin α2 are regulated by serum treatment. Exp Cell Res 312: 2983-2999. (Pubitemid 44292657)
27. Choi S, Lee SA, Kwak TK, Kim HJ, Lee MJ, et al. (2009) Cooperation between integrin α5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity. Blood 113: 1845-1855.
28. Lee MS, Kim HP, Kim TY, Lee JW (2012) Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition. Biochim Biophys Acta 1823: 514-523.
29. Radisky DC, Kenny PA, Bissell MJ (2007) Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 101: 830-839. (Pubitemid 47040865)
30. Hong IK, Jeoung DI, Ha KS, Kim YM, Lee H (2012) Tetraspanin CD151 stimulates adhesion-dependent activation of Ras, Rac, and Cdc42 by facilitating molecular association between β1 integrins and small GTPases. J Biol Chem 287: 32027-32039.